Her primary areas of study are Internal medicine, Endocrinology, Thyroid, Hypopituitarism and Quality of life. She has researched Internal medicine in several fields, including Pediatrics and Physiology. Her biological study spans a wide range of topics, including Cohort study and Cohort.
Her Thyroid research focuses on subjects like MEDLINE, which are linked to Thyroid disease, Content validity and Clinical research. Her studies deal with areas such as Mortality rate, Standardized mortality ratio, Adrenal adenoma, Pituitary ACTH hypersecretion and Statistical significance as well as Hypopituitarism. Her research integrates issues of Radioactive iodine, Nontoxic goiter, Physical therapy, Euthyroid and Comparative effectiveness research in her study of Quality of life.
Ulla Feldt-Rasmussen mostly deals with Internal medicine, Endocrinology, Thyroid, Pediatrics and Fabry disease. Her work in Internal medicine addresses subjects such as Gastroenterology, which are connected to disciplines such as Adrenal insufficiency. Ulla Feldt-Rasmussen integrates several fields in her works, including Endocrinology and Context.
Much of her study explores Thyroid relationship to Pregnancy. Her Pediatrics research is multidisciplinary, incorporating elements of Incidence and Cohort. Her research in Thyroglobulin intersects with topics in Autoantibody and Thyroid cancer.
Her main research concerns Internal medicine, Fabry disease, Endocrinology, Pediatrics and Cohort. Her biological study spans a wide range of topics, including Gastroenterology and Oncology. Her studies in Fabry disease integrate themes in fields like Urology, Renal function and Enzyme replacement therapy.
Her study in the fields of Acromegaly under the domain of Endocrinology overlaps with other disciplines such as Context. As a part of the same scientific family, Ulla Feldt-Rasmussen mostly works in the field of Cohort, focusing on Retrospective cohort study and, on occasion, Incidence. Her work carried out in the field of Thyroid brings together such families of science as Hormone, Cohort study and Intensive care medicine.
The scientist’s investigation covers issues in Internal medicine, Thyroid function, Endocrinology, Thyroid and Cohort. Ulla Feldt-Rasmussen has researched Internal medicine in several fields, including Gastroenterology and Oncology. Her study focuses on the intersection of Thyroid function and fields such as Pregnancy with connections in the field of Thyroid peroxidase, Obstetrics, Thyroid function tests, Thyroid disease and Odds ratio.
She integrates many fields in her works, including Endocrinology and Context. Her Thyroid research incorporates themes from Hormone, Cohort study, Physiology and Intensive care medicine. Ulla Feldt-Rasmussen combines subjects such as Urology, Pediatrics and Renal function with her study of Cohort.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Incidence and late prognosis of cushing's syndrome: a population-based study.
J. Lindholm;S. Juul;J. O. L. Jørgensen;J. Astrup.
The Journal of Clinical Endocrinology and Metabolism (2001)
Thyroid effects of endocrine disrupting chemicals
Malene Boas;Ulla Feldt-Rasmussen;Katharina M. Main.
Molecular and Cellular Endocrinology (2012)
Environmental chemicals and thyroid function
Malene Boas;Ulla Feldt-Rasmussen;Niels E Skakkebæk;Katharina M Main.
European Journal of Endocrinology (2006)
Females with Fabry disease frequently have major organ involvement : Lessons from the Fabry Registry
William R. Wilcox;William R. Wilcox;João Paulo Oliveira;Robert J. Hopkin;Alberto Ortiz.
Molecular Genetics and Metabolism (2008)
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
Dominique P Germain;Derralynn A Hughes;Kathleen Nicholls;Daniel G Bichet.
The New England Journal of Medicine (2016)
The Influence of Growth Hormone Deficiency, Growth Hormone Replacement Therapy, and Other Aspects of Hypopituitarism on Fracture Rate and Bone Mineral Density
Christian Wüster;Roger Abs;Bengt-Åke Bengtsson;Helge Bennmarker.
Journal of Bone and Mineral Research (2001)
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Derralynn A Hughes;Kathleen Nicholls;Suma P Shankar;Gere Sunder-Plassmann.
Journal of Medical Genetics (2017)
Childhood Exposure to Phthalates: Associations with Thyroid Function, Insulin-like Growth Factor I, and Growth
Malene Boas;Hanne Frederiksen;Ulla Feldt-Rasmussen;Niels E. Skakkebæk.
Environmental Health Perspectives (2010)
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
Marieke Biegstraaten;Reynir Arngrímsson;Frederic Barbey;Lut Boks.
Orphanet Journal of Rare Diseases (2015)
Pregnancy Outcome in Type 1 Diabetic Women With Microalbuminuria
Pia Ekbom;Peter Damm;Bo Feldt-Rasmussen;Ulla Feldt-Rasmussen.
Diabetes Care (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: